Loading drug development pipeline…
Loading drug development pipeline…
Derived
For each drug, the most advanced stage supported by registered interventional trials and jurisdiction-aware approval records. Approval in any ingested jurisdiction outranks trial phase; a drug is counted once, at its highest stage.
Computedci-drug-pipeline-v1Stage rulesApprovals feed →
Funnel
Drugs reach Leukemia through trial conditions or approval indications mapped to it or to one of its descendant entities.
26 drugs · 850 active trials
42 drugs · 1,288 active trials
Outside the funnel: Phase not stated 1 · Withdrawn 3. "Withdrawn" = every approval record for the scope is withdrawn or superseded; "phase not stated" = trials exist but none states a phase.
Data updated 15 minutes agoSource updated unknownrecomputed with the intelligence layer
Drugs
Most advanced stage first, then most active trials. Trial counts are interventional studies linking the drug (and, when a cancer is selected, the cancer).
| Drug | Stage | Max phase | Active | Recruiting | Phase 3 | Total trials | Approvals | Jurisdictions | First approval | First trial |
|---|---|---|---|---|---|---|---|---|---|---|
| Vorasidenib | Phase 1 | Phase 1 | 0 | 0 | 0 | 1 | 0 | — | — | Aug 7, 2015 |
| O6-Benzylguanine | Phase not stated | N/A | 0 | 0 | 0 | 1 | 0 | — | — | 2015-02 |
| Dasatinib | Withdrawn | Phase 4 | 28 | 11 | 15 | 134 | 1 | EU | — | Jul 13, 2001 |
| Ofatumumab | Withdrawn | Phase 4 | 3 | 2 | 8 | 45 | 1 | EU | — | 2004-10 |
| Moxetumomab Pasudotox | Withdrawn | Phase 3 | 1 | 0 | 1 | 6 | 1 | EU | — | May 10, 2007 |
Stages describe registered activity and ingested regulatory records, not efficacy. Only ingested jurisdictions (currently US and Canada) can place a drug at "approved"; trial phases are as registered by sponsors. Nothing here is a treatment recommendation.